GLP1R and obesity due to melanocortin 4 receptor deficiency: In this study, we presented evidence of the effectiveness of treatment with incretin GLP-1 for the symptoms of obesity and diabetes, inflammation and emphysema, as well as stimulation of regeneration of damaged endothelium of the lungs in conditions of modeling obesity and emphysema.